OssDsign Launches Cranial PSI in Japan Trauma The launch marks an important strategic milestone, following a period of postponed commercial activities due to the Covid-19 pandemic. Jun 21, 2022
COVID Abatement in First Quarter Brings Relief for Most Pressured Segments Chart of the Month Knee replacement, hip replacement and spine have been the most susceptible to disruption from procedure cancelations during the pandemic. Jun 15, 2022
Xenco Medical Expands ASC Device Portfolio Spine Xenco announced FDA clearance and launch of its Multilevel CerviKit, implants and single-use instruments for 2, 3 and 4 level anterior cervical spine procedures. Jun 14, 2022
Orthopedic Sales Off to Faster Than Expected Start in 2022 Market Analysis We estimate orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable. Jun 02, 2022
Medtronic Marks One Year of Transformation Company Revenue The company's renewed focus on competitiveness and market share paid off in its fiscal year 2022, as Medtronic grew in the mid-single digits. May 31, 2022
OrthoPediatrics’ Growing Surgeon Adoption Offsets Headwinds Company Revenue The company grew in the high single digits for 1Q22 as its non-elective trauma business offset COVID-related elective procedure headwinds. May 19, 2022
Surgalign Looks to Extend Runway for HOLO Platform Company Revenue The company declined in the double digits for 1Q22 as it continues the early commercialization efforts of its HOLO platform. May 19, 2022
Bioventus Focused on Double-Digit Growth and Debt Reduction Company Revenue The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year. May 17, 2022
Anika Gets Bounce from Order Timing in OA Pain Business Company Revenue The company grew in the low double digits for the first quarter of 2022 based on favorable order timing in its viscosupplement business. May 13, 2022
Globus Starts Slow But Reaffirms Guidance for 2022 Company Revenue The company grew in the low single digits for 1Q22 due to a tough comparison and a stagnant robotic sales pipeline. May 12, 2022